"Jurassic World" and the Dinosaurs at the USDA
By Rachel Smolker,
Truthout
| 06. 22. 2015
Untitled Document
The new movie Jurassic World offers more than a few lessons relevant to the state of our world. There is the obvious point about scientists bringing back to life genetically engineered dinosaurs with no real concern for the havoc they may wreak. Then there is the very clear link to real-world "de-extinction" scientists who seriously aim to bring back mastodons and passenger pigeons, while others are finding ever more potent means to mess around with the code of life to manufacture completely new organisms through synthetic biology.
There are also the dinosaur-like regulations of the US Department of Agriculture (USDA), developed way back in the 1980s before many of the new biotechnologies were even conceived. Those regulations are in desperate need of an overhaul if they are ever to protect the public from the onslaught of dangerous and unpredictable impacts that necessarily accompany the derailing of billions of years of evolution for the purpose of corporate profit-making.
Right now in fact, the USDA is in the process of evaluating and overhauling these antiquated regulations, a process that should...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...